RONALYN BARICEVIC: Open Payments
NPI 1528633690 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,415 in 175 payments from 27 companies in 2025. Trend: 2023 $2,176 · 2024 $2,992 · 2025 $3,415
Food & beverage: $3,318Education: $98
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $369 |
| AstraZeneca Pharmaceuticals LP | 9 | $347 |
| GlaxoSmithKline, LLC. | 26 | $347 |
| Grifols USA, LLC | 47 | $325 |
| Regeneron Healthcare Solutions, Inc. | 9 | $269 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $223 |
| Viatris Specialty LLC | 7 | $189 |
| Insmed, Inc. | 12 | $166 |
| Verona Pharma, Inc. | 5 | $159 |
| Inspire Medical Systems, Inc. | 3 | $141 |
Products named: DUPIXENT, Prolastin-C Liquid, FASENRA, OFEV, NUCALA, YUPELRI, Arikayce, Ohtuvayre.
Industry payments across AZ — which companies pay providers there.
